Service by

Home Journal Issues Instructions for Authors Editorial Board About Journal Aims & Scope


Original Research Open Access
RMJ. 2013; 38(2): 131-133


Comparison between 1%permethrin, Trimethoprim-sulfamethoxazole and Crotamiton in the treatment of Pediculosis capitis

Basel Alrawashdeh, Taghreed J Almaaita.

Abstract
Objective: to compare the efficacy of three different treatments for pediculosis capitis.
Materials and methods: a prospective study was carried out at Jordanian military field hospital in Gaza from August 2012 to October 2012.A total number of sixty patients were included in this study.Pediculosis capitis was diagnosed by direct examination of scalp and hair. The diagnosis was confirmed by direct light microscopic examination.
Patients were divided into three equal groups:
The first group received 1% permethrin cream, the second group received only oral Trimethoprim-sulfamethoxazole and the third group received crotamiton lotion.
To assess cure rate we followed these patients up to two and four weeks after completing their treatment. Absence of adults’ lice and nits was considered a cure.
Result: The group who received 1% permethrin cream showed the highest cure rate, while those who received oral Trimethoprim-sulfamethoxazole showed the lowest cure rate.
Conclusion: 1 % permethrin cream rinse was the best treatment to head lice to date, but oral TM-SMX therapy is not recommended.

Key words: Permethrin, crotamiton, pediculosis capitis


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Basel Alrawashdeh
Articles by Taghreed J Almaaita
on Google
on Google Scholar
Article Statistics
 Viewed: 1957
Downloaded: 427
Cited: 0


REFERENCES
1. Robert H Vander Stichele,Els M Dezeure,Marc G Bogaert.Systematic review of clinical efficacy of topical treatments for head lice.bmj 1995;311:604-608. [DOI via Crossref]   
2. Durden LA. Biting and sucking lice. . Arthropods of public health significance in California.Sacramento (CA): MVCAC; 2002. p. 37-44.
3. Christen JK and Dink ME. Pediculosis. J am acad dermatol 2004; 50:1-12. [DOI via Crossref]   
4. Dodd CS. Interventions for treating headlice.Cochrance database syst Rev 2000 ;( 2):CD001165.
5. Morsy TA, Ramadan NI.Mahmoud MS, Lashen AH.The efficacy of co-trimoxazole as an oral treatment for pediculosis capitis infestation.J Egypt SOC Parasitol 1996 Apr, 26(1):73-7.
6. Rasmussen JE. Antiparasitic agents.Comprehensive dermatologic drug therapy; 2001. p. 537-46.
7. Shashindran CH, Gandhi IS, Krishnasamy S, Ghosh MN. Oral therapy of Pediculosis capitis with cotrimoxazole. Br J Dermatol1978; 98:699-700.
8. Karacic I, Yawalker SJ. A single application of crotamiton lotion in the Treatment of patients with pediculosis capitis. Int J Dermatol1982; 21:611-13.
9. Craig GB, Craig NB and Kristina MB. An assessment of topical and oral prescription and over-the- counter treatments for head lice. J Am Acad Dermatol 1998; 38:979-82. [DOI via Crossref]   
10. Christine CJ and Elizabeth AA.parasitic infestations. J Am Acad Dermatol 2007; 56:1026043.
11. Mangrakar RR,Partridge SK,Korman AK,Barwick RS,Juranek DD.Efficacy of 1% permethrin for the treatment of head louse infestations among Kosovar refugees.Mil med 2000 Sep;165(9):698-700.
12. Amr ZS, Nusier MN.Pediculosis capitis in Northern Jordan.Int J Dermatol 2000 Dec; 39(12):919-21.
13. Hipolito RB, Mallorca FG, Zuniga Macaraig ZO, Apolinario PC, Wheeler-Sherman JI. Head lice infestation. Medscape medline pediatrics 2001 Mar; 107(3):E30.
14. Meinking TL,Entzel P,Villar ME,Vicaria M,Lemard JA,Porcelain SL.Comparitve efficacy of treatments for pediculosis capitis infestations. Arch dermatol 2001 Mar; 137(3):287-92.
15. Aditya G. Current management options for the treatment of head lice. J Am Acad Ddermatol 2008; AB84.

How to Cite this Article
Pubmed Style

Alrawashdeh B, Almaaita TJ. Comparison between 1%permethrin, Trimethoprim-sulfamethoxazole and Crotamiton in the treatment of Pediculosis capitis. RMJ. 2013; 38(2): 131-133.


Web Style

Alrawashdeh B, Almaaita TJ. Comparison between 1%permethrin, Trimethoprim-sulfamethoxazole and Crotamiton in the treatment of Pediculosis capitis. http://www.rmj.org.pk/?mno=29957 [Access: December 17, 2017].


AMA (American Medical Association) Style

Alrawashdeh B, Almaaita TJ. Comparison between 1%permethrin, Trimethoprim-sulfamethoxazole and Crotamiton in the treatment of Pediculosis capitis. RMJ. 2013; 38(2): 131-133.



Vancouver/ICMJE Style

Alrawashdeh B, Almaaita TJ. Comparison between 1%permethrin, Trimethoprim-sulfamethoxazole and Crotamiton in the treatment of Pediculosis capitis. RMJ. (2013), [cited December 17, 2017]; 38(2): 131-133.



Harvard Style

Alrawashdeh, B. & Almaaita, T. J. (2013) Comparison between 1%permethrin, Trimethoprim-sulfamethoxazole and Crotamiton in the treatment of Pediculosis capitis. RMJ, 38 (2), 131-133.



Turabian Style

Alrawashdeh, Basel, and Taghreed J Almaaita. 2013. Comparison between 1%permethrin, Trimethoprim-sulfamethoxazole and Crotamiton in the treatment of Pediculosis capitis. Rawal Medical Journal, 38 (2), 131-133.



Chicago Style

Alrawashdeh, Basel, and Taghreed J Almaaita. "Comparison between 1%permethrin, Trimethoprim-sulfamethoxazole and Crotamiton in the treatment of Pediculosis capitis." Rawal Medical Journal 38 (2013), 131-133.



MLA (The Modern Language Association) Style

Alrawashdeh, Basel, and Taghreed J Almaaita. "Comparison between 1%permethrin, Trimethoprim-sulfamethoxazole and Crotamiton in the treatment of Pediculosis capitis." Rawal Medical Journal 38.2 (2013), 131-133. Print.



APA (American Psychological Association) Style

Alrawashdeh, B. & Almaaita, T. J. (2013) Comparison between 1%permethrin, Trimethoprim-sulfamethoxazole and Crotamiton in the treatment of Pediculosis capitis. Rawal Medical Journal, 38 (2), 131-133.




Instructions for Authors

AUTHOR LOGIN

REVIEWER LOGIN

Indexed In

WHO Index Medicus IMEMR,
Emromedex,
Pakmedinet,
ExtraMED and
Scopus

Approved by the Higher Education Commission of Pakistan and Pakistan Medical and Dental Council



The articles in Rawal Medical Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.